TeamDrive
RUS
Maria Makarova

Maria Makarova

CFO

Телефоны:

+ 7 495 545 39 12

Send message

Additionally to participation in Team Drive Marya Maria is Chief Financial Officer at RMI Partners (venture capital investment company) and at pharmaceutical company NovaMedica.

Maria has over 15 years of experience in finance. She started her professional career at one of the "Big 4" companies, where she worked in the audit department for more than 12 years. Subsequently Maria participated in the creation and development of a large management company, where she was responsible for general operational project management of medical services and medical technology, in addition to her financial management responsibilities.

Maria Makarova holds a Bachelor’s degree in Mathematics and Finance, MBA and CPA (US Certified Public Accountant). 

In 2016, Maria was listed in the TOP-1000 Russian Managers rating released annually by the Managers Association of Russia and Kommersant Publishing House.

Media Center

  • 22 September 2017

    SPIC’s will ensure more predictability for pharmaceutical companies in Russia

    A meeting of the working group of the Coordination Council in the Area of Circulation of Medicines and Medical Devices held in the Russian Union of Industrialists and Entrepreneurs (RSPP) examined the state and development prospects of manufacturing the drugs for the treatment of oncological diseases in Russia.

  • 22 September 2017

    Cancer biobank Indivumed and CRO Helomics team up on precision medicine

    Indivumed, which has a large cancer biobank, has partnered with cancer research specialist Helomics to analyze human cancer biospecimens and relevant clinical datIndivumed, which has a large cancer biobank, has partnered with cancer research specialist Helomics to analyze human cancer biospecimens and relevant clinical data collected from patients around the world to help advance research in personalized cancer treatments. collected from patients around the world to help advance research in personalized cancer treatments.

  • 21 September 2017

    In a world of change, big pharma remains a constant

    Analysts casting their eyes forward to 2022 see big pharma maintaining its position in the sector, protected by vast war chests and ready to pounce on any newcomer that shows promise. Here pharmaphorum’s Andrew McConaghie crunches the numbers.

  • 20 September 2017

    India’s Zydus Cadila inks deal to produce varicella vaccine in Russia

    India’s Zydus Cadila inks deal to produce varicella vaccine in Russia

    Zydus Cadila, an Indian injectables maker, said it reached a deal with Russia’s Pharm Aid to manufacture its varicella vaccine for the Russian Federation. The Russians have been pressuring foreign pharmaceutical companies to engage in local production if they want to be in its market. Earlier this year, Russia-based NovaMedica announced it began work on a new plant in Russia’s Kaluga region where it will produce 30 of Pfizer’s sterile injected generic medications for the local market.

Read more